Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors

DNA and Cell Biology

Volumn 31, Issue 4, 2012, Pages 531-536

  Cigrovski Berković, Maja ^a   Catela Ivković, Tina ^b   Marout, Jasminka ^a   Zjačić Rotkvić, Vanja ^a   Kapitanović, Sanja ^b  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; AGED; ALLELE; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PANCREATIC NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84859752460     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1317     Document Type: Article

References (23)

1. Abdul, M., and Hoosein, N. (2002). Relationship of the interleukin-1 system with neuroendocrine and exocrine markers in human colon cancer cell lines. Cytokine 18, 86-91.
2. Ankarcrona, M., Dypbukt, J.M., Brune, B., and Nicotera, P. (1994). Interleukin-1b-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213, 172-177.
3. Apte, R.N., Dotan, S., Elkabets, M., White, M.R., Reich, E., Carmi, Y., Song, X., Dvozkin, T., Krelin, Y., and Voronov, E. (2006). The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25, 387-408.
4. Barber, M.D., Powell, J.J., Lynch, S.F., Fearon, K.C., and Ross, J.A. (2000). A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer 83, 1443-1447.
5. Chan, A.O., Kim, S.G., Bedeir, A., Issa, J.P., Hamilton, S.R., and Rashid, A. (2003). CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 22, 924-934.
6. Chen, G., Hohmeier, H.E., and Newgard, C.B. (2001). Expression of the Transcription Factor STAT-1a in Insulinoma Cells Protects against Cytotoxic Effects of Multiple Cytokines. J Biol Chem 276, 766-772.
7. Chen, H., Wilkins, L.M., Aziz, N., Cannings, C., Wyllie, D.H., Bingle, C., Rogus, J., Beck, J.D., Offenbacher, S., Cork, M.J., Rafie-Kolpin, M., Hsieh, C.M., Kornman, K.S., and Duff, G.W. (2006). Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15, 519-529.
8. Corbett, J.A., Sweetland, M.A., Wang, J.L., Lancaster, J.R., and McDaniel, M.L. (1993). Nitric oxide mediates cytokineinduced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A 90, 1731-1735.
9. Deans, D.A., Wigmore, S.J., Gilmour, H., Paterson-Brown, S., Ross, J.A., and Fearon, K.C. (2006). Elevated tumour interleukin-1beta is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer. Br J Cancer 95, 1568-1575.
10. Ebrahimi, B., Tucker, S.L., Li, D., Abbruzzese, J.L., and Kurzrock, R. (2004). Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101, 2727-2736.
11. El-Omar, E.M., Carrington, M., Chow, W.H., McColl, K.E., Bream, J.H., Young, H.A., Herrera, J., Lissowska, J., Yuan, C.C., Rothman, N., Lanyon, G., Martin, M., Fraumeni, J.F., Jr., and Rabkin, C.S. (2000). Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398-402.
12. Franko, J., Feng, W., Yip, L., Genovese, E., and Moser, A.J. (2010). Non-functional neuroendocrine carcinoma of the P pancreas: incidence, tumor biology, and outcomes in 2,158 patients. J Gastrointest Surg 14, 541-548.
13. Greco, E., Basso, D., Fogar, P., Mazza, S., Navaglia, F., Zambon, C.F., Falda, A., Pedrazzoli, S., Ancona, E., and Plebani, M. (2005). Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1. Int J Biol Markers 20, 235-241.
14. Hamacher, R., Diersch, S., Scheibel, M., Eckel, F., Mayr, M., Rad, R., Bajbouj, M., Schmid, R.M., Saur, D., and Schneider, G. (2009). Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer. Cytokine 46, 182-186.
15. House, M.G., Herman, J.G., Guo, M.Z., Hooker, C.M., Schulick, R.D., Cameron, J.L., Hruban, R.H., Maitra, A., and Yeo, C.J. (2003). Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. Surgery 134, 902-908.
16. Massironi, S., Sciola, V., Peracchi, M., Ciafardini, C., Spampatti, M.P., and Conte, D. (2008). Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol 14, 5377-5384.
17. Muerkoster, S., Wegehenkel, K., Arlt, A., Witt, M., Sipos, B., Kruse, M.L., Sebens, T., Kloppel, G., Kalthoff, H., Folsch, U.R., and Schafer, H. (2004). Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 64, 1331-1337.
18. Pociot, F., Molvig, J., Wogensen, L., Worsaae, H., and Nerup, J. (1992). A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22, 396-402.
19. Spaventi, R., Pecur, L., Pavelić, K., Pavelić, Z.P., Spaventi, S., and Stambrook, P.J. (1994). Human tumor bank in Croatia: a possible model for a small bank as a part of the future European Tumor Bank Network. Eur J Cancer 30A, 419.
20. ten Kate, M., Hofland, L.J., van Koetsveld, P.M., Jeekel, J., and van Eijck, C.H. (2006). Pro-inflammatory cytokines affect pancreatic carcinoma cell. Endothelial Cell Interact 7, 454-464.
21. Wang, Y., Kato, N., Hoshida, Y., Yoshida, H., Taniguchi, H., Goto, T., Moriyama, M., Otsuka, M., Shiina, S., Shiratori, Y., Ito, Y., and Omata, M. (2003). Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37, 65-71.
22. Yoshida, N., Ikemoto, S., Narita, K., Sugimura, K., Wada, S., Yasumoto, R., Kishimoto, T., and Nakatani, T. (2002). Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma. Br J Cancer 86, 1396-1400.
23. Zienolddiny, S., Ryberg, D., Maggini, V., Skaug, V., Canzian, F., and Haugen, A. (2004). Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer, Int J Cancer 109, 353-356.